Open AccessTumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature
Author(s) -
Frank Behrens,
Juan D. Cañete,
Ignazio Olivieri,
Arno W R van Kuijk,
Neil McHugh,
Bernard Combe
Publication year - 2014
Publication title -
rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.957
H-Index - 173
eISSN - 1462-0332
pISSN - 1462-0324
DOI - 10.1093/rheumatology/keu415
Subject(s) - medicine , concomitant , combination therapy , tnf inhibitor , observational study , randomized controlled trial , tumor necrosis factor alpha , oncology , adalimumab
The aim of this study was to review the available evidence on TNF inhibitor monotherapy vs combination therapy with MTX in PsA.